XML 30 R15.htm IDEA: XBRL DOCUMENT v3.20.4
Note 8 - Financial Instruments
12 Months Ended
Dec. 31, 2020
Notes to Financial Statements  
Financial Instruments Disclosure [Text Block]
8.
FINANCIAL INSTRUMENTS

 
Investments—Trading
 
Investments-Trading consisted of the following.
 
 
INVESTMENTS - TRADING
(Dollars in Thousands)
 
   
As of December 31,
 
   
2020
   
2019
 
U.S. government agency MBS and CMOs
  $
162,031
    $
196,146
 
U.S. government agency debt securities
   
6,904
     
14,680
 
RMBS
   
14
     
15
 
U.S. Treasury securities
   
607
     
11,105
 
ABS
   
1
     
100
 
SBA loans
   
2,742
     
27,634
 
Corporate bonds and redeemable preferred stock
   
36,388
     
38,503
 
Foreign government bonds
   
659
     
844
 
Municipal bonds
   
19,400
     
13,737
 
Certificates of deposit
   
70
     
841
 
Derivatives
   
13,717
     
3,686
 
Equity securities
   
428
     
561
 
Investments-trading
  $
242,961
    $
307,852
 
 
Trading Securities Sold,
Not
Yet Purchased
 
Trading securities sold,
not
yet purchased consisted of the following.
 
 
 
TRADING SECURITIES SOLD,
NOT
YET PURCHASED
(Dollars in Thousands)
 
   
As of December 31,
 
   
2020
   
2019
 
U.S. Treasury securities
  $
3,348
    $
16,827
 
Corporate bonds and redeemable preferred stock
   
29,206
     
58,083
 
Municipal bonds
   
20
     
20
 
Derivatives
   
11,822
     
3,017
 
Equity securities
   
43
     
-
 
Trading securities sold, not yet purchased
  $
44,439
    $
77,947
 
 
The Company tries to manage its exposure to changes in interest rates for the interest rate sensitive securities it holds by entering into offsetting short positions for similar fixed rate securities. See note
5
for realized and unrealized gains recognized on investments-trading and trading securities sold,
not
yet purchased.
 
Other Investments, at Fair Value
 

 
Other investments, at fair value consisted of the following.
 
OTHER INVESTMENTS, AT FAIR VALUE
(Dollars in Thousands)
 
   
As of December 31, 2020
 
   
Cost
   
Carrying Value
   
Unrealized Gain / (Loss)
 
Equity securities
  $
15,605
    $
51,593
    $
35,988
 
Corporate bonds and redeemable preferred stock    
479
     
476
     
(3
)
Subordinated Notes    
1,485
     
1,519
     
34
 
RTLs
   
2,243
     
2,300
     
57
 
U.S. Insurance JV
   
1,168
     
1,564
     
396
 
SPAC Funds
   
779
     
984
     
205
 
Residential loans
   
119
     
104
     
(15
)
Other investments, at fair value
  $
21,878
    $
58,540
    $
36,662
 
 
OTHER INVESTMENTS SOLD,
NOT
YET PURCHASED
(Dollars in Thousands)
 
   
As of December 31, 2020
 
   
Cost
   
Carrying Value
   
Unrealized Gain / (Loss)
 
Derivatives   $
338
    $
233
     
105
 
Equity securities
   
7,223
     
7,182
     
41
 
Other investments sold, not yet purchased
  $
7,561
    $
7,415
    $
146
 
 
OTHER INVESTMENTS, AT FAIR VALUE
(Dollars in Thousands)
 
   
As of December 31, 2019
 
   
Cost
   
Carrying Value
   
Unrealized Gain / (Loss)
 
Equity securities
  $
8,119
    $
8,875
    $
756
 
Corporate bonds and redeemable preferred stock    
479
     
477
     
(2
)
CLOs
   
2,894
     
2,522
     
(372
)
U.S. Insurance JV
   
2,048
     
2,223
     
175
 
SPAC Funds
   
646
     
668
     
22
 
Residential loans
   
129
     
99
     
(30
)
Other investments, at fair value
  $
14,315
    $
14,864
    $
549